Detalhe da pesquisa
1.
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
Circulation
; 149(16): e1113-e1127, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38465648
2.
Androgen Deprivation Therapy/Androgen Receptor Signaling Inhibitor Treatments for Prostate Cancer: Pathophysiology and Review of Effects on Cardiovascular Disease.
South Med J
; 117(5): 245-253, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701845
3.
Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
Cancer
; 127(4): 598-608, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33151547
4.
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
Circulation
; 137(8): e30-e66, 2018 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437116
5.
Sex Differences in Cardio-Oncology: Considerations for the Practicing Clinician and Researcher.
Circulation
; 145(7): 510-512, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157522
6.
Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.
Pharm Res
; 34(2): 427-437, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27943014
7.
Bendamustine and Rituximab: Complete Response in a 62-Year-Old Female with an Aggressive Lymphoma and an Ejection Fraction of 20.
Chemotherapy
; 62(2): 140-146, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27960150
8.
A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Pharm Res
; 33(11): 2704-12, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27506424
9.
Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.
Pharm Res
; 33(8): 1817-32, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27194002
10.
A Model-Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk.
Clin Pharmacol Drug Dev
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757461
11.
Immune Checkpoint Inhibitors and Cardiotoxicity: A Comparative Meta-Analysis of Observational Studies and Randomized Controlled Trials.
J Am Heart Assoc
; 13(10): e032620, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38761070
12.
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
Cardiooncology
; 10(1): 3, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225669
13.
Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score.
J Am Heart Assoc
; 13(1): e033599, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158222
14.
NEW-ONSET CARDIAC AMYLOIDOSIS WHILE IN REMISSION FROM SYSTEMIC AL AMYLOIDOSIS.
Eur J Case Rep Intern Med
; 10(2): 003768, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36970162
15.
Unusual vasovagal-type autonomic dysfunction secondary to immune checkpoint inhibitor therapy.
BMJ Case Rep
; 16(2)2023 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36805877
16.
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: JACC: CardioOncology State-of-the-Art Review.
JACC CardioOncol
; 5(2): 159-173, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37144116
17.
Artificial intelligence modelling to assess the risk of cardiovascular disease in oncology patients.
Eur Heart J Digit Health
; 4(4): 302-315, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37538144
18.
Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk Factors.
JACC CardioOncol
; 5(6): 821-832, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38205002
19.
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative.
Circ Cardiovasc Qual Outcomes
; 16(10): e009905, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702048
20.
Buccal films: A review of therapeutic opportunities, formulations & relevant evaluation approaches.
J Control Release
; 352: 1071-1092, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351519